Gem Aromatics Q1 FY27 earnings call

Gem Aromatics Limited reported a consolidated revenue of ₹99 crores in Q1 FY27, marking a 12.5% year-over-year growth, while standalone revenue reached ₹83 crores, up 9.2% YoY. Despite revenue growth, the company recorded a consolidated PAT loss of ₹7.9 crores, significantly impacted by a higher depreciation of ₹9.1 crores following the capitalization of the Dahej facility. Consolidated EBITDA margin stood at a low 3.3%, primarily due to an unfavorable product mix, elevated raw material costs in the clove business, and the increased operating cost base of the new plant.

The Dahej facility, operating under Krystal Ingredients Private Limited, is advancing through its commercialization phase, with nearly ₹265 crores of the total ₹270 crores plant capex already incurred and substantially capitalized. The company's strategic focus is on strengthening customer engagement and expanding commercial opportunities across new product categories. This multipurpose manufacturing platform is designed to offer flexibility for evolving customer requirements and build a broader specialty product portfolio, with a gradual improvement expected as new verticals scale up.

Commercial production for Safranal has commenced, with initial revenue contribution anticipated by the end of Q2 FY27 and a more meaningful impact from Q3 FY27. For cooling agents (Gemcool 3, 5, and 23), customer audits are complete, initial orders secured, and significant revenue contribution is also expected from Q3 FY27. Phenol derivatives are slated for trial production by the end of Q2 FY27, with commercial production targeted for Q3 FY27 and meaningful revenue contribution projected from Q4 FY27, primarily from the export market.

A key part of Gem Aromatics' long-term strategy is to reduce dependence on the traditional mint portfolio and build a more balanced mix with non-mint and higher-value specialty products. Innovation and R&D are central to this strategy, focusing on process innovation, product customization, and the development of higher-value specialty molecules. Management expects Krystal products to contribute over 50% of the overall revenue by FY28, indicating a significant shift in the company's product mix.

The clove business experienced a significant setback in Q1 FY27 due to severe floods in Madagascar, a primary source of raw materials. This resulted in a 30-day closure of the Toamasina port, causing delays in raw material shipments and affecting availability and pricing. While the company noted that incoming material has resumed since May, and they expect to be close to planned numbers by year-end, the incident highlighted the vulnerability of the supply chain.

To strengthen its global footprint, Gem Aromatics has approved the incorporation of a Brazil subsidiary, aiming to enhance distribution in Latin America for its essential oils, aromatic chemicals, and specialty chemicals. Regarding working capital, the company expects a lower cycle for Krystal products compared to its traditional business, as synthetic products require less inventory holding. Additionally, the company plans to utilize factoring services to reduce debtor days, optimizing liquidity.